SCHEMBL20111549

SCHEMBL20111549

N#Cc1c(-n2c3ccccc3c3cc(-c4ccccc4)ccc32)cc(-c2ccc(C(F)(F)F)cc2C(F)(F)F)cc1-n1c2ccccc2c2cc(-c3ccccc3)ccc21

nearest known ligand 0.37

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 5/20 0.37
TDP1 Q9NUW8 3/20 0.37
MAPT P10636 1/20 0.37
SMN1; SMN2 Q16637 1/20 0.37
KIF11 P52732 3/20 0.34
KDM4E B2RXH2 4/20 0.33
HPGD P15428 3/20 0.33
GAA P10253 2/20 0.33
EDNRB P24530 1/20 0.33
EDNRA P25101 1/20 0.33
AR P10275 1/20 0.33
GLA P06280 1/20 0.33
TSPO P30536 1/20 0.33
CYP2C9 P11712 1/20 0.32
SCN9A Q15858 1/20 0.32
ALOX5AP P20292 1/20 0.32
FEN1 P39748 1/20 0.32
L3MBTL1 Q9Y468 3/20 0.32
S1PR1 P21453 2/20 0.32
S1PR3 Q99500 2/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20111844 0.97 ALDH1A1 (0.39) ALDH1A1TDP1MAPTSMN1; SMN2KIF11
SCHEMBL20111566 0.95 AR (0.38) ALDH1A1TDP1MAPTSMN1; SMN2KIF11
SCHEMBL20111557 0.94 KIF11 (0.40) ALDH1A1TDP1MAPTSMN1; SMN2KIF11
SCHEMBL21258771 0.94 ALDH1A1 (0.37) ALDH1A1TDP1MAPTSMN1; SMN2KIF11
SCHEMBL21258749 0.93 AR (0.39) ALDH1A1TDP1MAPTSMN1; SMN2KIF11
SCHEMBL20111560 0.93 KIF11 (0.34) ALDH1A1TDP1MAPTSMN1; SMN2KIF11
SCHEMBL20925149 0.93 KIF11 (0.38) ALDH1A1TDP1MAPTSMN1; SMN2KIF11
SCHEMBL21258670 0.92 PTPN5 (0.39) ALDH1A1TDP1MAPTSMN1; SMN2KIF11
SCHEMBL20111819 0.92 KIF11 (0.40) ALDH1A1TDP1MAPTSMN1; SMN2KIF11
SCHEMBL20112001 0.92 AR (0.43) ALDH1A1TDP1MAPTSMN1; SMN2KIF11

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10971688-B2 Organic molecules for use in organic optoelectronic devices CYNORA GMBH (DE) 2021-04-06 US disclosed
US-20190248741-A1 ORGANIC MOLECULES FOR USE IN ORGANIC OPTOELECTRONIC DEVICES SAMSUNG DISPLAY CO., LTD. (KR) 2019-08-15 US disclosed
WO-2018077492-A1 ORGANIC MOLECULES, ESPECIALLY FOR USE IN ORGANIC OPTOELECTRONIC DEVICES CYNORA GMBH (DE) 2018-05-03 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10971688-B2 Organic molecules for use in organic optoelectronic devices OR10J3, OR51E2, OPRM1 ALDH1A1 65/4885TDP1 2554/4885MAPT 1511/4885
US-20190248741-A1 ORGANIC MOLECULES FOR USE IN ORGANIC OPTOELECTRONIC DEVICES OR10J3, ORC3, AOC3 ALDH1A1 654/4885TDP1 4101/4885MAPT 2738/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.